Israel Englander Dexcom Inc Call Options Transaction History

Millennium Management LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$110.31 - $140.45 $13.3 Million - $16.9 Million	120,500 Added 268.37%	165,400 $18.8 Million
Q1 2024 May 15, 2024	SELL	$114.22 - $140.1 $331,238 - $406,290	-2,900 Reduced 6.07%	44,900 $6.23 Million
Q4 2023 Feb 14, 2024	SELL	$75.49 - $124.16 $6.04 Million - $9.93 Million	-80,000 Reduced 62.6%	47,800 $5.93 Million
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $5.42 Million - $6.31 Million	48,200 Added 60.55%	127,800 $16.4 Million
Q1 2023 May 15, 2023	SELL	$104.0 - $122.92 $22.1 Million - $26.1 Million	-212,600 Reduced 72.76%	79,600 $9.25 Million
Q4 2022 Feb 14, 2023	BUY	$84.98 - $122.67 $19.3 Million - $27.8 Million	227,000 Added 348.16%	292,200 $33.1 Million
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $1.51 Million - $1.86 Million	-19,800 Reduced 23.29%	65,200 $5.25 Million

1,057

358M

4.11M

3.63M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $26.5B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.